FERTILITY AREA

The first part of this session will be about how IVF has changed over the last 40 years. From Louise Brown to today, we have managed to increase significantly the success rates and take-home baby rates. We will travel throughout ART phases, from 1st IVF drugs used for ovarian stimulation, to the new and modern approach on medications, trigger and egg collection.
The second part will be about the integration of artificial intelligence (AI) into in vitro fertilization (IVF) offers transformative potential for improving outcomes, efficiency, and patient care. This lecture explores how AI is reshaping the landscape of human reproduction by enhancing embryo selection, optimizing stimulation protocols, predicting success rates, and personalizing treatment pathways. Through machine learning algorithms and big data analytics, clinicians can now access predictive tools that support more precise decision-making and reduce human variability. Additionally, AI-driven imaging and time-lapse technologies provide deeper insights into
embryo viability, while natural language processing is improving patient engagement and education. The session will address current advancements, ethical considerations, regulatory challenges, and the evolving role of clinicians in an AI-augmented reproductive environment. Ultimately, this lecture will offer a forward-looking perspective on how AI is set to redefine IVF, moving us closer to the vision of truly individualized reproductive medicine.
The last part Patient satisfaction in fertility care is a critical outcome that directly influences adherence to treatment, emotional well-being, and clinical success rates. This presentation explores five pillars of patient-centered fertility care: effective multidisciplinary communication, psychological support, clear and evidence-based education, streamlined integration of treatment protocols, and a supportive physical environment. Updated for 2025, the session includes emerging trends such as AI-assisted embryo selection, digital patient engagement tools, and telehealth in reproductive medicine. Attendees will gain actionable strategies to reduce
patient dropout and enhance care quality through empathy, clarity, and technology.

Follicle-stimulating hormone (FSH) and luteinizing hormone (LH) deficiencies present unique diagnostic and therapeutic challenges in reproductive endocrinology. This session provides a comprehensive overview of pathophysiology, diagnostic criteria, and patient selection strategies for individuals affected by gonadotropin deficiency. Emphasis will be placed on identifying clinical indicators, hormonal profiles, and imaging findings that guide appropriate diagnosis and treatment planning. Evidence-based protocols for hormone replacement, ovulation induction, and long-term management will be discussed, along with insights into optimizing individualized care to enhance fertility outcomes.

The session will include a panel discussion on what can cause a suboptimal response to rFSH? Ais a suboptimal response to rFSH could be predicted? How can we optimize circulating LH levels during rFSH-driven COS?

A highlight of the session is an interactive clinical case workshop, where real-world scenarios will be analyzed to reinforce theoretical knowledge with practical application. Attendees will gain a structured approach to managing FSH/LH deficiency, ensuring both effective and patient-centered care in diverse clinical settings.

The first part of this session will be about the new management of hyper responders’ patients, their risks and how to improve safety & efficacy. It’s about how to select, predict and identify these patients at risk.

The main objective of this talk is to avoid OHSS and to increase the take home baby rates in these patients.

The panel discussion will tackle different cases at risk for being hyper responders:

1. Ovarian stimulation of a hyper responder oncology patient coming for fertility preservation
2. Suboptimal response to an “agonist trigger” in a hyper responder patient
3. Luteal phase support in case of having to do fresh transfer in a hyper responder patient
4. Low LH level on the day of trigger and the use of low dose HCG to avoid suboptimal egg collection

In recent years the way we stimulate and trigger these cases is very important and we must ensure we do it the best way possible. In modern times it is not acceptable to have IVF patients hyper
stimulated and at risk of suffering life threatening conditions.

The second part of this session will be about Infertility in patients with systemic conditions such as thyroid dysfunction and multiple sclerosis (MS) that presents complex challenges and demands a multidisciplinary approach. The session will provide practical advice on how to assess and manage these patients, including when to refer for fertility treatment and how to balance medical care with fertility goals. Real clinical cases will be discussed to show how to apply these concepts in everyday practice.